Eagle Meds Services
RHAPSIDO (remibrutinib)
Available to sourceHuman Prescription DrugOncology & Specialty

RHAPSIDO (remibrutinib)

25 mg/1 · Tablet
By Novartis Pharmaceuticals Corporation
NDC
0078-1483
Route
Oral
Therapeutic class
Bruton's Tyrosine Kinase Inhibitors [MoA], Kinase Inhibitor , P-Glycoprotein Inhibitors [MoA]
Marketing category
NDA

Package sizes

  • 2 BOTTLE in 1 CARTON (0078-1483-92) / 30 TABLET in 1 BOTTLENDC 0078-1483-92Available to order
  • 30 TABLET in 1 BOTTLE (0078-1483-93)NDC 0078-1483-93Available to order
  • 60 TABLET in 1 BOTTLE (0078-1483-20)NDC 0078-1483-20Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
RHAPSIDO (remibrutinib)
NDC 0078-1483
(980) 480-3410 requests@eaglemedsservices.com

Related in Oncology & Specialty

See all →
Verzenio (abemaciclib)

Verzenio (abemaciclib)

50 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

200 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

100 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

150 mg/1 · Tablet
Eli Lilly and Company
Available to source